ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

BGS vs MED // PIOTROSKI F-SCORE QUALITY

B&G Foods Inc. (NYSE) VS. MEDIFAST INC (NYSE) • 15-METRIC TALLY: BGS 5 — MED 4
■ METRIC PARITY
piotroski-score
5/9
piotroski-score
5/9
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (BGS VS. MED) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC BGS MED SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 21.80% 71.30% -49.50 MED /gross-margins <GO>
Return on Invested Capital (ROIC) 3.30% -10.20% +13.50 BGS /roic <GO>
EV/EBITDA & P/E Valuation 16.8x — — TIE /valuation <GO>
Free Cash Flow Yield — 0.91% — TIE /fcf-yield <GO>
Operating Margin 5.30% -3.70% +9.00 BGS /operating-margins <GO>
Net Profit Margin -2.40% -4.90% +2.50 BGS /net-margins <GO>
Revenue Growth (YoY) -5.40% -36.00% +30.60 BGS /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.14% -0.14 MED /dividend-safety <GO>
Altman Z-Score & Debt/Equity 1.24 4.71 -3.47 MED /balance-sheet <GO>
Piotroski F-Score Quality ACTIVE 5/9 5/9 0.00 TIE /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 43.2 54.3 -11.10 MED /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $183.7M $137.1M $46.6M BGS /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR BGS REV MED REV BGS GROSS % MED GROSS % BGS FCF MED FCF
FY 2025 $1.83B $385.8M 21.8% 71.3% $70.7M $1.2M
FY 2024 $1.93B $602.5M 21.8% 73.8% $103.7M $17.0M
FY 2023 $2.06B $1.07B — — $247.8M $147.7M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
BGS // BETA —
MED // BETA —